The DMRDP Assistive Technologies Research Award (ATRA) is intended to support research focused on novel technologies with the potential to have a major impact on the restoration of vision, hearing, and/or balance following traumatic injuries. Studies can range from proof of concept (i.e. first in human) trials through Phase II clinical trials, as well as Class I, II, or III medical device trials/testing.
Studies involving drugs or biologics are not allowed. All studies must be responsive to the health care needs of military Service Members and Veterans, and all applications must specifically and clearly address the military relevance of the proposed research; however, the use of military populations in the proposed research is not a requirement. Proposed projects should be designed to demonstrate the effectiveness and further evaluate the safety of novel assistive technologies for sensory substitution/augmentation in human patients suffering from serious, debilitating visual, auditory, and/or vestibular injuries due to trauma.
For more information, visit: